DJIA 18,232.02 -53.72 -0.29%
NASDAQ 5,089.36 -1.43 -0.03%
S&P 500 2,126.06 -4.76 -0.22%
market minute promo

Gilead Sciences (NASDAQ: GILD)



company name or ticker
Company Photos
(Click to zoom)

Healthcare Investment Opportunities for the Long Term

Three healthcare investment opportunities that could be profitable for decades to come.

The Most Loved Biotechs of Big Hedge Funds

Novartis Announces Positive Data on Oncology Drug Afinitor - Analyst Blog

Novartis Announces Positive Data on Oncology Drug Afinitor - Analyst Blog

Kite Pharma Starts Dosing in Phase I/II Study on KTE-C19 - Analyst Blog

5 Dividend Companies With 10-15% Growth

J&J (JNJ) to File for More than 10 New Products by 2019 - Analyst Blog

Bristol-Myers' HCV Combination Designation Amended by FDA - Analyst Blog

Bristol-Myers' HCV Combination Designation Amended by FDA - Analyst Blog

Achillion Pharmaceuticals: Should You Buy After The Sell-Off?

Johnson & Johnson Just Stepped Up Its Hepatitis C Game

Johnson & Johnson has inked a licensing deal with Achillion Pharmaceuticals that could threaten Gilead Sciences market share in hepatitis C. Should Gilead investors worry?

Gilead, Merck And Achillion/J&J Square Off In An HCV 'Nuc'lear Showdown

See More Articles...